Singapore Exchange (SGX) and Marex Spectron, a UK-based tech-enabled liquidity hub, announced their collaboration on March 16, where SGX will add Marex’s ferrous derivative data analytics products to its Titan OTC platform.
Titan OTC is a one-stop, full-service over-the-counter platform that supports block trade registration, order management, content and analytics across multiple asset classes and trading instruments. It was launched in 2016 to bring together clearing members, brokers and clients on to a single platform.
Titan OTC hosts both SGX and partner-generated content and data within the Titan content hub that brings together multi-asset content for the derivatives community.
SEE:CICT issues $250 mil in fixed rate notes due 2032 with 2.15% p.a. coupon
Through the collaboration, Marex will apply its proprietary analytics tools on publicly available data for SGX commodity derivatives to provide Titan OTC participants with in-depth analysis and richer datasets.
“With increasing financialisation of commodities products, SGX continues to connect clients and market participants to global metals and energy, and financial markets. Our collaboration with Marex Spectron will enable us to provide clients with actionable data and insights. We look forward to more partnerships and initiatives to bring transparency and efficiency to OTC workflows,” says Daniel Hildebrand, SGX’s head of digital services.
See also: The future of neurotechnology: merging minds and machines
“Over the last decade we have focused on quantitative innovation in metals to provide our clients with a range of unique proprietary analytical products and insights into their markets. To be chosen by SGX as a partner for their Titan OTC platform is an exciting opportunity and a privilege, and we look forward to building out a new range of products for ferrous derivative traders,” adds Dr Guy Wolf, global head of market analytics at Marex Spectron and CEO of Marex Spectron Asia.
Shares in SGX closed 8 cents lower or 0.8% down at $10 on March 16.
